Find a TenderAwarded
Published 27 Nov 2023, 10:59 GMT

Official UK procurement notice

RSV Immunisations (2024) · UK public procurement notice

Official notice

Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)

4 lotsGoodsOpen procedureMax 2 lots per supplier
Awarded value£22 contracts · exc. VAT
Submissions closed 29 Feb 2024awarded 5 Jun 2024
Awarded to Pfizer Ltd2 awards

Re-procurement plannedRSV immunisation products - Adults · tender expected

What is being bought4 lots · detail below

Published requirement description

Contracts for the supply of immunisation products indicated for the prevention of or protection from Respiratory Syncytial Virus (RSV) lower respiratory tract disease

CPV: Immune sera and immunoglobulins · Vaccines

Lots and requirements (4)Procurement structure

4 lots · no lot values published · win at most 2 of them
Lot #1A monoclonal antibody for infants

The provision of a product indicated for the prevention of or protection from Respiratory Syncytial Virus (RSV) in infants from birth, including pre-term infants, weighing less than 5 kilograms by direct passive immunisation of the infant by means of a monoclonal antibody.

Delivery: UK, London · To a location(s) in the United Kingdom to be notified to the successful bidder(s) following contract award.
Extensions: This contract has the option of a break clause after 12 months.<br/>This contract has the option to be extended for a period or periods up to an additional 24 months.Variant bids: not allowed
Lot #2A vaccine which provides maternal protectionAwarded

Contract for the provision of a maternal vaccine indicated for the prevention of or protection against RSV lower respiratory tract disease in infants. Lot 2a requires a volume to support an annual vaccination programme. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

Delivery: UK, London · UK
Extensions: This contract has the option to be extended for a period or periods up to an additional 24 monthsVariant bids: not allowed
Lot #3A vaccine for older adults (annual cohort)

The provision of a product indicated for the prevention of or protection from Respiratory Syncytial Virus (RSV) in a routine single annual cohort of older adults.

Delivery: UK, London · To a location(s) in the United Kingdom to be notified to the successful bidder(s) following contract award.
Extensions: This contract has the option of a break clause after 12 months.<br/>This contract has the option to be extended for a period or periods up to an additional 24 months.Variant bids: not allowed
Lot #4A vaccine for older adults (annual cohort and a catchup volume)Awarded

Contract for the provision of a vaccine indicated for the prevention of or protection against RSV lower respiratory tract disease in adults 60 years of age and above (one routine cohort of adults as part of an annual vaccination programme with a catch-up programme in the first year) Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

Delivery: UK, London · UK
Extensions: This contract has the option to be extended for a period or periods up to an additional 24 monthsVariant bids: not allowed

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
27 Nov 2023, 10:59 GMT
Last source update
12 Jun 2024, 11:12 BST
Award evaluation window
29 Feb 2024 – …
Authority reference
CM/PHV/24/C199417
FTS notice number
2024/S 000-018141
Classification (CPV)
Immune sera and immunoglobulinsVaccines
Delivery area
UKLondon (UKI32)
Official registry OCID
ocds-h6vhtk-041ce9 Find a Tender

Publisher note: The contracts are for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective immunisation programmes.<br/><br/>Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated

Tender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗

Submission deadline
29 Feb 2024, 13:00 GMT
Submission channel
{"electronicSubmission","written"}
Accepted languages
en
Bid validity
270 days from the deadline
Bids opened
29 Feb 2024, 13:00 GMT
Detailed submission instructions & authority contactsFrom official release

Timeline

15 Jan 2024 → 12 Jun 2024 · 4 dates
  1. Next notice expected
    15 Jan 2024
  2. Submission deadline
    29 Feb 2024, 13:00 GMT
  3. Bids opened
    29 Feb 2024, 13:00 GMT
  4. Notice published
    12 Jun 2024, 11:12 BST

Notice history

4 events · 3 releases on Find a Tender · since 24 Jan 2024
  1. Status changed to active
    24 Jan 2024, 16:13 GMT
  2. Procurement method changed
    24 Jan 2024, 16:13 GMT
  3. Deadline published: 29 Feb 2024, 13:00 GMT
    24 Jan 2024, 16:13 GMT
  4. Status changed to complete
    12 Jun 2024, 11:12 BST

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 2
Awarded value £22 contracts exc. VAT
Bids received 3
Contracts signed 2latest 5 Jun 2024

Contracts

  • Contract 018141-2024-1 · Pfizer Ltd

    Signed
    5 Jun 2024
    Value
    £1
    Status
    active
  • Contract 018141-2024-2 · Pfizer Ltd

    Signed
    5 Jun 2024
    Value
    £1
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
2 · A vaccine which provides maternal protection1bids · 1 electronic0——
4 · A vaccine for older adults (annual cohort and a catchup volume)2bids · 2 electronic0——

Contracting authority & participating public bodies

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Contracting authorityCentral GovernmentMinistry or any other national or federal authority, including their regional or local subdivisionsHealth 10 South Colonnade, London, London, E14 4PUContact name, email Published organisation website ↗

Dispute resolution & review bodies

  • The High CourtReview body London

Bidders & participating suppliers

1 commercial party on the notice
  • Pfizer LtdAwarded supplier Walton Oaks, Dorking Road, Kent, UK, KT20 7NS

Official documents & specifications (2)

Official links; attachments are not copied

Tender pack and attachments

  • Economic and financial selection criteriatenderEconomic and financial selection criteria
  • Technical selection criteriatenderTechnical selection criteria